atropine has been researched along with penicillamine in 13 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (penicillamine) | Trials (penicillamine) | Recent Studies (post-2010) (penicillamine) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 7,415 | 312 | 442 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Day, MD; Hall, JM; Owen, DA | 1 |
| Barkhatova, VP; Gotovtseva, EV; Ivanova-Smolenskaia, IA; Markova, ED; Tkachev, RA | 1 |
| Wirth, W | 1 |
| Dikshit, M; Shukla, A; Srimal, RC | 1 |
| Itoh, T; Kamisaki, Y; Moriwaki, Y | 1 |
| Hatano, Y; Iranami, H; Ogawa, K; Tajima, T; Yamamoto, M | 1 |
| Bonfante-Cabarcas, R; Castañeda-Perozo, D; Gutiérrez-Reyes, E; Moreno-Yanez, J; Nello-Pérez, C; Papale-Centofanti, J; Pascuzzo-Lima, C | 1 |
1 review(s) available for atropine and penicillamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for atropine and penicillamine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Selective inhibition of angiotensin pressor responses in the pithed rat by tetraethylthiuram disulphide (disulfiram) and sodium diethyldithiocarbamate (DDC).
Topics: Angiotensin II; Animals; Ascorbic Acid; Atropine; Blood Pressure; Disulfiram; Dose-Response Relationship, Drug; Drug Synergism; Electric Stimulation; Heart Rate; Male; Norepinephrine; Penicillamine; Rats; Reserpine; Sympathetic Nervous System; Thiocarbamates; Tubocurarine; Vasopressins | 1972 |
[Principles of the pathogenetic therapy of congenital extrapyramidal diseases].
Topics: Adolescent; Adult; Atropine; Basal Ganglia Diseases; Chelating Agents; Chronic Disease; Dihydroxyphenylalanine; Female; Hepatolenticular Degeneration; Humans; Hyperkinesis; Male; Pantothenate Kinase-Associated Neurodegeneration; Parkinson Disease; Penicillamine; Phenothiazines; Pyridoxine; Sulfhydryl Compounds; Trifluoperazine; Tropanes | 1973 |
[Possible side-effects of antidotal therapy].
Topics: Antidotes; Atropine; Chelating Agents; Cyanides; Deferoxamine; Dimercaprol; Edetic Acid; Humans; Hydroxocobalamin; Metals; Nitrites; Penicillamine; Pentetic Acid; Phenols; Phosphates; Poisoning; Pralidoxime Compounds; Thiosulfates | 1968 |
Nitric oxide-dependent blood-brain barrier permeability alteration in the rat brain.
Topics: Animals; Arginine; Atropine; Blood Pressure; Blood-Brain Barrier; Heart Rate; Kinetics; Microcirculation; Molsidomine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Penicillamine; Permeability; Rats; Rats, Sprague-Dawley; Reference Values; S-Nitroso-N-Acetylpenicillamine; Vasodilator Agents | 1996 |
[cGMP synthesis induced by atrial natriuretic peptide, C-type natriuretic peptide, and nitric oxide in the rat retina].
Topics: Animals; Atrial Natriuretic Factor; Atropine; Benzoates; Calcimycin; Carbachol; Cyclic GMP; Imidazoles; In Vitro Techniques; Ionophores; Male; Natriuretic Peptide, C-Type; Nitric Oxide; Nitroarginine; Penicillamine; Proteins; Rats; Rats, Wistar; Retina; S-Nitroso-N-Acetylpenicillamine | 1996 |
Halothane and isoflurane attenuate the relaxant response to nonadrenergic and noncholinergic nerve stimulation of isolated canine cerebral arteries.
Topics: Animals; Atropine; Cerebral Arteries; Dinoprost; Dogs; Electric Stimulation; Endothelium, Vascular; Female; Halothane; Isoflurane; Male; Nitric Oxide; Penicillamine; Propranolol; Vasodilation; Vasodilator Agents | 1998 |
Supersensitivity of the cholinergic muscarinic system in the rat's brain is induced by high concentrations of Cu+2.
Topics: Animals; Atropine; Brain Chemistry; Cerebral Cortex; Chelating Agents; Cholinergic Fibers; Copper Sulfate; Corpus Striatum; Dose-Response Relationship, Drug; Hippocampus; Male; Maze Learning; Memory; Motor Activity; Muscarinic Agonists; Muscarinic Antagonists; Nerve Tissue Proteins; Penicillamine; Pyridoxine; Quinuclidinyl Benzilate; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Zinc Sulfate | 2002 |